Such a model links the wide array of diverse bodies of data pertaining to MS, including data on stress, obesity, melatonin, orexin, the kynurenine pathway, oxidative stress, depression, inflammation, gut dysregulation, mitochondria dysfunction, platelet activation, thrombin, and increased myocardial infarction risk. This evidence concerns the gene HCRT and depressive symptom measurement.